Also Noted

Obama proposes cut to Medicare Advantage

 - 
02/25/2014

WASHINGTON – The Obama administration has proposed cutting reimbursements rates for Medicare Advantage (MA) plans by 1.9% in 2015, Kaiser Health News reports.

CMS to test ICD-10 claims

 - 
02/24/2014

WASHINGTON – CMS plans to conduct testing of ICD-10 billing submissions across a wide range of fee-for-service providers.

RESNA announces conference speakers

 - 
02/24/2014

WASHINGTON – Former Indy 500 driver Sam Schmidt, founder of the Sam Schmidt Paralysis Foundation, will open RESNA’s “Racing Towards Excellence in AT” conference.

Philips Respironics recalls 600 vents

 - 
02/20/2014

MURRYSVILLE, Pa. – Philips Respironics initiated a worldwide recall of 600 Trilogy Ventilators, models 100, 200 and 202, according to a Feb. 19 release.

ResMed founder named to CONNECT Hall of Fame

 - 
02/20/2014

SAN DIEGO – ResMed Founder Peter Farrell has been inducted into the CONNECT Entrepreneur Hall of Fame for his work in sleep and respiratory medicine, the company announced Feb. 19.

CGS launches manual wheelchair review

 - 
02/20/2014

NASHVILLE, Tenn. – High strength, lightweight manual wheelchairs will be the subject of a service-specific prepayment review because of their high claims payment error rate, CGS, the Jurisdiction C DME MAC, announced Feb. 18.

CareCentrix, Cigna stick together

 - 
02/19/2014

HARTFORD, Conn. – CareCentrix has re-upped its partnership with Cigna, inking a five-year agreement to coordinate home health services, including nursing, home infusion and HME to its members, according to a press release.

Patent tug-of-war continues

 - 
02/19/2014

SAN DIEGO – Apex Medical has initiated challenges to four ResMed patents, it announced today. Apex has initiated challenges in the European Patent Office, the German Federal Patent Court, and the German Patent and Trade Mark Office.

INGN opens for trading

 - 
02/18/2014

GOLETA, Calif. – Inogen (INGN) opened for trading on the NASDAQ on Feb. 14, pricing about 4.4 million shares of its stock at $16 per share, the low end of an expected range of $16 to $18. On Feb. 18, the company’s stock was trading at $15.28 per share.

Sleep apnea study reaches milestone

 - 
02/18/2014

ANDOVER, Mass. – The Sleep Apnea cardioVascular Endpoints Study (SAVE) has enrolled 2,500 patients, Royal Philips, a major sponsor, announced Feb. 18. The patients are spread across seven countries, and 84 hospitals and medical institutions.

Pages